Barbara Łasut-Szyszka

5PUBLICATIONS
11CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Basic pharmacologyMolecular targetsInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 12, 2025
Gemcitabine and Flurbiprofen Enhance Cytotoxic Effects on Cancer Cell Lines Mediated by Mesenchymal Stem Cells.

Agata Kawulok, Paulina Borzdziłowska, Magdalena Głowala-Kosińska

|Feb 10, 2025
Ultrasound-assisted synthesis of new bisphosphonate-betulin conjugates and preliminary evaluation of their cytotoxic activity.

Dominika Kozicka, Małgorzata Krześniak, Mirosława Grymel

|Jul 27, 2024
The Strong Activation of p53 Tumor Suppressor Drives the Synthesis of the Enigmatic Isoform of DUSP13 Protein.

Małgorzata Krześniak, Barbara Łasut-Szyszka, Agnieszka Będzińska

|Apr 28, 2023
The Wheel of p53 Helps to Drive the Immune System.

Barbara Łasut-Szyszka, Marek Rusin

|Oct 23, 2021
Transcriptome Analysis of Cells Exposed to Actinomycin D and Nutlin-3a Reveals New Candidate p53-Target Genes and Indicates That CHIR-98014 Is an Important Inhibitor of p53 Activity.

Barbara Łasut-Szyszka, Beata Małachowska, Agnieszka Gdowicz-Kłosok

Pageof 1